Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
2.
Zhonghua Yu Fang Yi Xue Za Zhi ; 57(4): 566-571, 2023 Apr 06.
Article in Chinese | MEDLINE | ID: mdl-37032166

ABSTRACT

As a single-center retrospective study, we analyzed the results of rotavirus and human adenovirus antigens in stool samples with colloidal gold immunochromatography method in children with acute gastroenteritis under the age of five who were treated in our hospital from 2019 to 2022. After excluding nonconforming cases and duplicate cases, 2 896 cases were included, of which 559 cases were detected with at least one viral antigen. According to the test results, they were divided into RV positive group, HAdV positive group and RV & HAdV double positive group. The gender, age, seasonal distribution, clinical symptoms and related laboratory tests were compared and analyzed with χ2 test, analysis of variance and nonparametric test. Among the single samples from 2 896 children, the positive rate of RV antigen was 6.21% (180/2 896), the positive rate of HAdV antigen was 10.91% (316/2 896), and the double positive rate of RV & HAdV was 2.18% (63/2 896). The positive rate of HAdV antigen in 2021 was 16.11%, a significant increase compared with 6.20% in 2020. RV infection has obvious seasonality, and spring and winter are the seasons with high incidence of infection (χ2=74.018, P<0.001), while HAdV infection has no obvious seasonality (χ2=2.110, P=0.550), showing sporadic infection throughout the year. The proportions of fever and vomiting symptoms in children with RV infection were significantly higher than those in the HAdV infection group (χ2=40.401, P<0.001; χ2=32.593, P<0.001), but the positive rate of white blood cells in the stool was significantly lower than that in the HAdV infection group (χ2=13.741,P<0.01). In summary, paying attention to the epidemiological changes of RV and HAdV is of great significance for clinical diagnosis and treatment and disease prevention and control.


Subject(s)
Adenovirus Infections, Human , Adenoviruses, Human , Gastroenteritis , Rotavirus , Child , Humans , Infant , Retrospective Studies , Gastroenteritis/epidemiology , Hospitals , Feces , Adenovirus Infections, Human/epidemiology
3.
J Physiol Pharmacol ; 73(4)2022 Aug.
Article in English | MEDLINE | ID: mdl-36696241

ABSTRACT

The aim of this study is to examine the role and functional mechanism of circ-FADS2 in colorectal cancer (CRC). The levels of expression of circ-FADS2 were detected in 48 patients with CRC and their paired normal tissue samples and cell lines (SW480, SW620, HCT116, HT29, and NCM460) using quantitative real-time polymerase chain reaction (qRT-PCR). Circ-FADS2 was then silenced in SW480 and HT29 cells using two small interfering ribonucleic acids. Themolecular mechanism of circ-FADS2 in CRC progression and migration was then examined by sponging miR-498 and promoting S100A16 expression. After this, the expression of miR-498 and S100A16 in CRC tissues was analyzed using a qRT-PCR. In results: circ-FADS2 was found to be significantly upregulated in CRC tissues, when compared with paired normal tissues. Higher circ-FADS2 expression was associated with advanced stages, lymphatic metastasis, and reduced overall survival (OS). In addition, silencing circ-FADS2 markedly inhibited the proliferation and invasion of CRC and increased the percentage of cancer cells in the G1 phase in vitro. Reducing circ-FADS2 decreased SW480 cell proliferation in vivo. By inhibiting miR-498 expression, circ-FADS2 promoted S100A16 expression leading to the activation of the AKT pathway, resulting in CRC progression. We conclude that Circ-FADS2 expression was upregulated in CRC tissues and cells and was found to be correlated with advanced cancer, metastasis, and poor OS. A study of the molecular mechanism suggests that a circ-FADS2/miR-498/S100A16/AKT signaling cascade may be a potential therapeutic target for the treatment of CRC.


Subject(s)
Colorectal Neoplasms , MicroRNAs , Humans , MicroRNAs/genetics , MicroRNAs/metabolism , Proto-Oncogene Proteins c-akt/metabolism , RNA, Circular/genetics , RNA, Circular/metabolism , Colorectal Neoplasms/genetics , Colorectal Neoplasms/metabolism , Cell Proliferation/genetics , Fatty Acid Desaturases/metabolism , S100 Proteins
4.
Genet Mol Res ; 14(2): 6819-29, 2015 Jun 18.
Article in English | MEDLINE | ID: mdl-26125889

ABSTRACT

The objective of this study was to clone the full-length cDNA of the APETALA1 (AP1) gene from lotus and analyze its sequence and expression pattern. The full-length cDNA sequence of the NnAP1 gene was amplified from the petals of Nelumbo nucifera 'Hongxia' using RT-PCR and rapid amplification of cDNA ends. Bioinformatic methods were used to analyze the sequence characteristics of the gene. Quantitative real-time PCR methods were used to investigate the expression pattern of NnAP1 in various organs and during different developmental stages. The cloned full-length NnAP1 cDNA (GenBank accession No. KF361315) was 902 bp, containing a 795-bp open reading frame encoding 264 amino acids with a relative molecular mass of 30,288.4 and an isoelectric point of 9.13. NnAP1 had a MADS-box domain and a K-box domain, which is typical of the SQUA/AP1 gene family. A protein sequence identity search showed that NnAP1 was 75-96% similar to other plant AP1s. Phylogenetic tree analysis indicated that NnAP1 was very closely related to AP1 of Glycine max, suggesting that they shared the same protein ancestor. Quantitative real-time PCR analysis showed that NnAP1 was expressed in various organs during different developmental stages; it had the highest expression in blooming flowers and had trace expression in the young vegetative and flower senescence stages. Our analysis suggests that NnAP1 plays an important role in controlling floral meristem identity and floral organ formation.


Subject(s)
Arabidopsis Proteins/genetics , Flowers/genetics , Gene Expression Regulation, Plant , MADS Domain Proteins/genetics , Meristem/genetics , Nelumbo/genetics , Amino Acid Sequence , Arabidopsis/genetics , Arabidopsis/growth & development , Arabidopsis/metabolism , Arabidopsis Proteins/metabolism , Cloning, Molecular , DNA, Complementary/genetics , DNA, Complementary/metabolism , Flowers/growth & development , Flowers/metabolism , Gene Expression Regulation, Developmental , MADS Domain Proteins/metabolism , Meristem/growth & development , Meristem/metabolism , Molecular Sequence Data , Nelumbo/classification , Nelumbo/growth & development , Nelumbo/metabolism , Open Reading Frames , Phylogeny , Sequence Alignment , Sequence Homology, Amino Acid , Glycine max/genetics , Glycine max/growth & development , Glycine max/metabolism
5.
Climacteric ; 17(4): 325-35, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24188229

ABSTRACT

OBJECTIVE: To compare by meta-analysis the efficacy and adverse events of Hypericum perforatum L. (St. John's Wort), or its combinations, and placebo for menopausal women. DESIGN: A systematic review and meta-analysis were carried out by searching in Pubmed, Cochrane Library, Embase and the Web of Science database. RESULTS: Extracts of Hypericum perforatum L. and its combination with herbs were significantly superior to placebo (standard mean difference = -1.08; 95% confidence interval -1.38 to -0.77); extracts of Hypericum perforatum L. proved to be more effective than placebo in the treatment of menopause. Adverse events occurred in 53 (17.4%) patients on Hypericum perforatum L. preparations and 45 (15.4%) patients on placebo (relative risk = 1.16; 95% confidence interval 0.81-1.66). CONCLUSION: Extracts of Hypericum perforatum L. have possibly fewer side-effects than placebo for the treatment of menopausal women.


Subject(s)
Depression/drug therapy , Hot Flashes/drug therapy , Hypericum , Menopause , Phytotherapy , Adult , Confidence Intervals , Depression/etiology , Female , Hot Flashes/etiology , Humans , Menopause/drug effects , Menopause/physiology , Menopause/psychology , Middle Aged , Plant Extracts/administration & dosage , Plant Extracts/adverse effects , Randomized Controlled Trials as Topic , Treatment Outcome
6.
J Pharm Biomed Anal ; 40(2): 417-22, 2006 Feb 13.
Article in English | MEDLINE | ID: mdl-16143483

ABSTRACT

1,5-Dicaffeoylquinic acid (1,5-DCQA) is a potentially important HIV-1 integrase inhibitor widely distributed in many plants. To characterize the pharmacokinetic and metabolic properties of 1,5-DCQA in rats following single intravenous administration (160 mg/kg), the plasma concentrations of 1,5-DCQA were measured by high-performance liquid chromatography (HPLC) and the metabolites formed in urine were identified by liquid chromatography-mass spectrometry (LC-MS) in parallel to diode-array detection (DAD). The results showed that the concentrations of 1,5-DCQA in plasma declined rapidly in a biphasic manner with a mean terminal half-life (t(1/2)) of 1.40 h. The mean clearance (CL) and the apparent volume of distribution (Vd(B)) of 1,5-DCQA were 0.44l/h/kg and 0.89l/kg, respectively. A total of 15 metabolites in rat urine were identified, including four isomeric O-mono-methylated (M1-M4), six isomeric O-di-methylated (M5-M10), one isomeric O-mono-methyl-glucuronidated (M11) and four isomeric O-di-methyl-glucuronidated (M12-M15) metabolites. The O-methylation positions of three important metabolites (M1, M2 and M5) were determined (3''-, 3'-, and 3',3''-) by comparing with synthesized standards. These results suggested that the disappearance of 1,5-DCQA from plasma was rapid, and that its quick urinary excretion and extensive metabolism, including methylation and glucuronidation, were two factors causing its rapid elimination from the circulation.


Subject(s)
Cinnamates/pharmacokinetics , HIV Integrase Inhibitors/pharmacokinetics , Animals , Chromatography, High Pressure Liquid/methods , Cinnamates/urine , Glucuronides/urine , HIV Integrase Inhibitors/urine , Injections, Intravenous , Male , Mass Spectrometry , Methylation , Rats , Rats, Wistar , Reproducibility of Results
7.
Mol Gen Genet ; 264(1-2): 2-10, 2000 Sep.
Article in English | MEDLINE | ID: mdl-11016827

ABSTRACT

A rice transcript, Rim2, was identified that accumulated in both incompatible and compatible interactions between rice and Magnaporthe grisea. The Rim2 transcript also accumulated in response to treatment with a cell wall elicitor derived from M. grisea. A 3.3-kb RIM2 cDNA clone was isolated and is predicted to encode a protein of 653 amino acids, which shares 32 55% identity with TNP2-like proteins encoded by CACTA transposons of other plants. A 1.05-kb segment of the Rim2 sequence shows 82% nucleotide sequence identity with sequences flanking the A1 and C members of the rice Xa21 disease resistance gene family. The 5'-upstream region of Rim2 was cloned and the transcriptional start sites were identified. The 5' and 3' noncoding termini of Rim2 are AT-rich. A cis-element showing similarity to a sequence that mediates defense-associated transcriptional activation of the tobacco retrotransposon Tnt1, and four motifs that fit the consensus sequence of the elicitor-responsive elements in the promoters of the parsley PR-1 genes were found in the 5'-upstream region. Four imperfect tandem repeats were identified in the 3' noncoding terminus. Southern analysis with genomic DNA from different rice species indicated that Rim2 is present in 3-4 copies per genome. These results suggest that Rim2 may be one component of a large CACTA-like element, whose transcript accumulates in response to attack by pathogens.


Subject(s)
Carrier Proteins/genetics , Carrier Proteins/metabolism , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Oryza/genetics , Plant Proteins/genetics , Plant Proteins/metabolism , Transposases , Amino Acid Sequence , Base Sequence , Cloning, Molecular , DNA Transposable Elements/genetics , Gene Dosage , Gene Expression Regulation, Plant , Magnaporthe/genetics , Molecular Sequence Data , Oryza/microbiology , Plant Diseases/genetics , Plant Diseases/microbiology , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , Sequence Homology, Amino Acid
8.
Yao Xue Xue Bao ; 27(1): 26-32, 1992.
Article in Chinese | MEDLINE | ID: mdl-1529709

ABSTRACT

From the ethanol extract of the Anemarrhena asphodeloides Buge (Liliaceae), a new steroidal suponin anemarsaponin B and two known saponins anemarsaponin A1 and A2 were isolated. On the basis of chemical evidences and spectral analysis (UV, IR, EI-MS, FAB-MS, 1H-NMR and 13C-NMR), the structure of anemarsaponin B was elucidated as 26-O-beta-D-glucopyranosylfurost-20(22)-ene-3 beta,26-diol-3-O-beta-D- glucopyranosyl(1----2)-beta-D-galactopyranoside. Preliminary pharmacological tests showed that anemarsaponin B could inhibit PAF-induced rabbit platelet aggregation in vitro.


Subject(s)
Drugs, Chinese Herbal/chemistry , Platelet Aggregation Inhibitors/isolation & purification , Saponins/isolation & purification , Triterpenes , Animals , Platelet Aggregation/drug effects , Platelet Aggregation Inhibitors/chemistry , Platelet Aggregation Inhibitors/pharmacology , Rabbits , Saponins/chemistry , Saponins/pharmacology
9.
Planta Med ; 57(5): 460-2, 1991 Oct.
Article in English | MEDLINE | ID: mdl-1798801

ABSTRACT

A new active steroidal saponin, anemarsaponin B, was isolated from the rhizomes of Anemarrhina asphodeloides. The structure of anemarsaponin B was elucidated as 26-O-beta-D-glucopyranosylfurost-20(22)-ene-3 beta, 26-diol-3-O-beta-D-glucopyranosyl-(1----2)-beta-D-galactopyranoside by chemical and spectral studies. Preliminary pharmacological tests showed that anemarsaponin B could inhibit PAF-induced rabbit platelet aggregation in vitro.


Subject(s)
Drugs, Chinese Herbal/chemistry , Platelet Aggregation Inhibitors/isolation & purification , Saponins/isolation & purification , Triterpenes , Animals , Carbohydrate Sequence , Drugs, Chinese Herbal/pharmacology , Female , Male , Molecular Sequence Data , Molecular Structure , Platelet Aggregation Inhibitors/pharmacology , Rabbits , Saponins/chemistry , Saponins/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...